Ticker Symbol: BLSA
BCLS Acquisition Corp - Class A
$9.91 - 04-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001823200
Company Profile
BCLS Acquisition Corp. is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to pursue investments, primarily based in North America and Europe and selectively in other geographies, including Asia and emerging markets, in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies. The Company is sponsored by an affiliate of Bain Capital Life Sciences, a leading life sciences investment manager.
Sector: N/A
Industry: N/A
Standard Industrial Classification Code (SIC code): N/A
Address: N/A
Website: bclsacquisitioncorp.com
CEO: N/A
Tags:
- Finance
- Financial Conglomerates
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $10.02 - $10.03
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 14862500
Valuation
Market Cap: 14.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A